Pfizer : PFE

All Pfizer Articles

1482 Articles

Jon C. Ogg | Nov 17, 2020 at 6:49 AM EST

Warren Buffett Makes Monumental Changes in Bank, Pharma, Tech Stock Holdings

Some rather significant changes were made in the Berkshire Hathaway equity portfolio during the third quarter.

Paul Ausick | Nov 16, 2020 at 9:39 AM EST

Moderna’s COVID-19 Vaccine Results Lift Blue Chips

Moderna reported a 95.4% effectiveness rate for its COVID-19 vaccine. This is the second vaccine to hit more than 90%…

Jon C. Ogg | Nov 10, 2020 at 8:59 AM EST

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Biogen, Cars.com, Levi Strauss, Maxeon, Nvidia, Pfizer, Plug Power, Square, Wayfair and More

Tuesday's top analyst upgrades and downgrades included AbbVie, Beyond Meat, Biogen, Eli Lilly, Levi Strauss, Nvidia, Pfizer, Plug Power, Raytheon,…

Chris Lange | Nov 9, 2020 at 9:45 AM EST

Efficacy in Pfizer and BioNTech COVID-19 Study Rocks the Market

Pfizer and BioNTech stocks both exploded on Monday after these companies provided an update on their coronavirus vaccine.

Jon C. Ogg | Oct 28, 2020 at 7:01 PM EDT

Did Regeneron Just Revive Hopes About Beating COVID-19?

The novel coronavirus has wiped out trillions of dollars in global output with more than 1 million deaths worldwide in…

Jon C. Ogg | Oct 28, 2020 at 8:56 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Caterpillar, Corning, DexCom, Enphase, First Solar, Invesco, 3M, Microsoft, Pfizer, Wynn and More

Wednesday's top analyst upgrades and downgrades included Advanced Micro Devices, Caterpillar, Corning, DexCom, Enphase Energy, First Solar, Invesco, 3M, Microsoft,…

Chris Lange | Oct 27, 2020 at 10:49 AM EDT

Do Merck and Pfizer Earnings Signal a Pullback in Health Care?

Merck and Pfizer reported their most recent quarterly results before the opening bell Tuesday, and investors were not thrilled about…

Chris Lange | Oct 25, 2020 at 6:10 AM EDT

Amazon, Alphabet, Facebook, Starbucks, Ford, GE, and More Major Earnings Coming This Week

This week will be perhaps the biggest week of earnings season, with many major names reporting, including Amazon, Facebook, Ford…

Chris Lange | Oct 16, 2020 at 10:46 AM EDT

What’s the Next Step for Pfizer and BioNTech’s Coronavirus Vaccine?

While other companies seem to be struggling with their coronavirus vaccines, Pfizer and BioNTech are just picking up speed. Pfizer’s…

Jon C. Ogg | Oct 5, 2020 at 1:28 PM EDT

Are President Trump’s COVID-19 Drugs the Real Winners in the Race?

Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that…

Chris Lange | Oct 2, 2020 at 11:58 AM EDT

Where We Stand on a Vaccine After Trump Catches COVID-19

President Trump and the First Lady have tested positive for COVID-19. That begs the question, now more than ever, of…

Lee Jackson | Sep 30, 2020 at 7:42 AM EDT

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

These companies have a very good shot at crossing the finish line first with a COVID-19 vaccine. Even those that…

Jon C. Ogg | Sep 29, 2020 at 9:05 AM EDT

Top Analyst Upgrades and Downgrades: AbbVie, CSX, Dominion, JPMorgan, NXP, ONEOK, Pfizer, Square, UPS, WPX Energy and More

Tuesday's top analyst upgrades and downgrades included AbbVie, CSX, Dominion Energy, JPMorgan, NXP Semiconductors, ONEOK, Pfizer, Square, United Parcel Service…

Jon C. Ogg | Sep 23, 2020 at 10:48 AM EDT

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

The race for the COVID-19 vaccine is still very much on, and Johnson & Johnson just announced the launch of…

Chris Lange | Sep 19, 2020 at 9:26 AM EDT

This Week in Coronavirus News

As an approved COVID-19 vaccine nears completion in terms of clinical trials, what can we expect? In the past couple…

1 … 19 20 21 22 23 … 99

Pfizer : PFE

All Pfizer Articles

Warren Buffett Makes Monumental Changes in Bank, Pharma, Tech Stock Holdings

Moderna’s COVID-19 Vaccine Results Lift Blue Chips

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Biogen, Cars.com, Levi Strauss, Maxeon, Nvidia, Pfizer, Plug Power, Square, Wayfair and More

Efficacy in Pfizer and BioNTech COVID-19 Study Rocks the Market

Did Regeneron Just Revive Hopes About Beating COVID-19?

Top Analyst Upgrades and Downgrades: AMD, Caterpillar, Corning, DexCom, Enphase, First Solar, Invesco, 3M, Microsoft, Pfizer, Wynn and More

Do Merck and Pfizer Earnings Signal a Pullback in Health Care?

Amazon, Alphabet, Facebook, Starbucks, Ford, GE, and More Major Earnings Coming This Week

What’s the Next Step for Pfizer and BioNTech’s Coronavirus Vaccine?

Are President Trump’s COVID-19 Drugs the Real Winners in the Race?

Where We Stand on a Vaccine After Trump Catches COVID-19

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

Top Analyst Upgrades and Downgrades: AbbVie, CSX, Dominion, JPMorgan, NXP, ONEOK, Pfizer, Square, UPS, WPX Energy and More

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

This Week in Coronavirus News

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

Pfizer : PFE

All Pfizer Articles

Warren Buffett Makes Monumental Changes in Bank, Pharma, Tech Stock Holdings

Moderna’s COVID-19 Vaccine Results Lift Blue Chips

Top Analyst Upgrades and Downgrades: AbbVie, Beyond Meat, Biogen, Cars.com, Levi Strauss, Maxeon, Nvidia, Pfizer, Plug Power, Square, Wayfair and More

Efficacy in Pfizer and BioNTech COVID-19 Study Rocks the Market

Did Regeneron Just Revive Hopes About Beating COVID-19?

Top Analyst Upgrades and Downgrades: AMD, Caterpillar, Corning, DexCom, Enphase, First Solar, Invesco, 3M, Microsoft, Pfizer, Wynn and More

Do Merck and Pfizer Earnings Signal a Pullback in Health Care?

Amazon, Alphabet, Facebook, Starbucks, Ford, GE, and More Major Earnings Coming This Week

What’s the Next Step for Pfizer and BioNTech’s Coronavirus Vaccine?

Are President Trump’s COVID-19 Drugs the Real Winners in the Race?

Where We Stand on a Vaccine After Trump Catches COVID-19

4 Companies in Late-Stage Coronavirus Vaccine Testing: Will Big Pharma Win the Race?

Top Analyst Upgrades and Downgrades: AbbVie, CSX, Dominion, JPMorgan, NXP, ONEOK, Pfizer, Square, UPS, WPX Energy and More

The Advantage Johnson & Johnson’s Phase 3 COVID-19 Study Has Over Rivals

This Week in Coronavirus News

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

Most Income Investors Have Never Heard of These 3 ETFs Paying Over 10 Percent Monthly

The Home Sale That Adds $5,880 a Year to a Retiree’s Medicare Premium Two Years Later

Featured Reads

Why a $2.1 Million 401(k) Holder Is Moving From California to Nevada Before His First RMD at 73

The Home Sale That Adds $5,880 a Year to a Retiree's Medicare Premium Two Years Later